These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 15858023)
1. An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors. Catalucci D; Sporeno E; Cirillo A; Ciliberto G; Nicosia A; Colloca S J Virol; 2005 May; 79(10):6400-9. PubMed ID: 15858023 [TBL] [Abstract][Full Text] [Related]
2. Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3. Gorziglia MI; Lapcevich C; Roy S; Kang Q; Kadan M; Wu V; Pechan P; Kaleko M J Virol; 1999 Jul; 73(7):6048-55. PubMed ID: 10364357 [TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII. Andrews JL; Kadan MJ; Gorziglia MI; Kaleko M; Connelly S Mol Ther; 2001 Mar; 3(3):329-36. PubMed ID: 11273775 [TBL] [Abstract][Full Text] [Related]
4. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement. Ji L; Bouvet M; Price RE; Roth JA; Fang B Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089 [TBL] [Abstract][Full Text] [Related]
5. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants. Krougliak V; Graham FL Hum Gene Ther; 1995 Dec; 6(12):1575-86. PubMed ID: 8664382 [TBL] [Abstract][Full Text] [Related]
6. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector. Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924 [TBL] [Abstract][Full Text] [Related]
7. A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors. Mizuguchi H; Kay MA Hum Gene Ther; 1999 Aug; 10(12):2013-7. PubMed ID: 10466635 [TBL] [Abstract][Full Text] [Related]
8. Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity. Osada T; Yang XY; Hartman ZC; Glass O; Hodges BL; Niedzwiecki D; Morse MA; Lyerly HK; Amalfitano A; Clay TM Cancer Gene Ther; 2009 Sep; 16(9):673-82. PubMed ID: 19229288 [TBL] [Abstract][Full Text] [Related]
9. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. Brough DE; Lizonova A; Hsu C; Kulesa VA; Kovesdi I J Virol; 1996 Sep; 70(9):6497-501. PubMed ID: 8709289 [TBL] [Abstract][Full Text] [Related]
10. Characterization of human adenovirus 35 and derivation of complex vectors. McVey D; Zuber M; Ettyreddy D; Reiter CD; Brough DE; Nabel GJ; King CR; Gall JG Virol J; 2010 Oct; 7():276. PubMed ID: 20959004 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. Lusky M; Christ M; Rittner K; Dieterle A; Dreyer D; Mourot B; Schultz H; Stoeckel F; Pavirani A; Mehtali M J Virol; 1998 Mar; 72(3):2022-32. PubMed ID: 9499056 [TBL] [Abstract][Full Text] [Related]
12. Conditional repression of the E2 transcription unit in E1-E3-deleted adenovirus vectors is correlated with a strong reduction in viral DNA replication and late gene expression in vitro. Rittner K; Schultz H; Pavirani A; Mehtali M J Virol; 1997 Apr; 71(4):3307-11. PubMed ID: 9060700 [TBL] [Abstract][Full Text] [Related]
13. A new vector system with inducible E2a cell line for production of higher titer and safer adenoviral vectors. Zhou H; Beaudet AL Virology; 2000 Sep; 275(2):348-57. PubMed ID: 10998335 [TBL] [Abstract][Full Text] [Related]
14. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. Yeh P; Dedieu JF; Orsini C; Vigne E; Denefle P; Perricaudet M J Virol; 1996 Jan; 70(1):559-65. PubMed ID: 8523570 [TBL] [Abstract][Full Text] [Related]
15. A single short stretch of homology between adenoviral vector and packaging cell line can give rise to cytopathic effect-inducing, helper-dependent E1-positive particles. Murakami P; Pungor E; Files J; Do L; van Rijnsoever R; Vogels R; Bout A; McCaman M Hum Gene Ther; 2002 May; 13(8):909-20. PubMed ID: 12031124 [TBL] [Abstract][Full Text] [Related]
16. Effects of first generation E1E3-deleted and second generation E1E3E4-deleted/modified adenovirus vectors on human endothelial cell death. Jornot L; Petersen H; Lusky M; Pavirani A; Moix I; Morris ; Rochat T Endothelium; 2001; 8(3):167-79. PubMed ID: 11824470 [TBL] [Abstract][Full Text] [Related]
17. Protease-deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy. Oualikene W; Lamoureux L; Weber JM; Massie B Hum Gene Ther; 2000 Jun; 11(9):1341-53. PubMed ID: 10890743 [TBL] [Abstract][Full Text] [Related]
18. Hybrid yeast-bacteria cloning system used to capture and modify adenoviral and nonviral genomes. Hokanson CA; Dora E; Donahue BA; Rivkin M; Finer M; Mendez MJ Hum Gene Ther; 2003 Mar; 14(4):329-39. PubMed ID: 12659674 [TBL] [Abstract][Full Text] [Related]
19. Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted. Amalfitano A; Hauser MA; Hu H; Serra D; Begy CR; Chamberlain JS J Virol; 1998 Feb; 72(2):926-33. PubMed ID: 9444984 [TBL] [Abstract][Full Text] [Related]
20. Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted. Zhou H; O'Neal W; Morral N; Beaudet AL J Virol; 1996 Oct; 70(10):7030-8. PubMed ID: 8794347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]